| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $0.1B | $-0.0B | $-0.4B | $-0.1B | $-1.7B | $0.1B | $-0.2B |
| EPS (Basic) | $1.32 | $0.65 | $-0.85 | $-12.21 | $-0.48 | $-9.89 | $0.75 | $-1.54 |
| EPS (Diluted) | $1.32 | $0.65 | $-0.85 | $-12.21 | $-0.48 | $-9.89 | $0.75 | $-1.54 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.5B | $5.7B | $5.3B | $5.1B | $8.4B | $8.6B | $22.3B | $17.8B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.1B | $0.1B | $0.1B | $0.2B | $0.4B | $0.1B | $0.2B | $0.1B |
| Total Liabilities | $5.7B | $5.0B | $4.5B | $4.3B | $7.0B | $7.3B | $19.4B | $15.5B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.8B | $0.7B | $0.8B | $0.8B | $1.4B | $1.4B | $2.9B | $2.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.3B | $0.3B |
| Investing Cash Flow | $-0.9B | $-0.5B | $-0.5B | $2.4B | $0.1B | $11.6B | $-4.3B | $0.6B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $0.7B | $0.3B | $0.2B | $-2.9B | $-0.1B | $-11.6B | $4.1B | $-0.9B |